Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2010, Pages 129-135

  Jeffrey Maisels, M ^a  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

Breastfeeding; Kernicterus; Neonatal hyperbilirubinemia; Screening and risk identification; Transcutaneous bilirubin

Indexed keywords

BILIRUBIN; MESOPORPHYRIN TIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BREAST FEEDING; DRUG MECHANISM; FOLLOW UP; GESTATIONAL AGE; HUMAN; KERNICTERUS; NEWBORN; NEWBORN JAUNDICE; NEWBORN SCREENING; POSTNATAL CARE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

BILIRUBIN; GUIDELINES AS TOPIC; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; NEONATAL SCREENING; NOMOGRAMS; RISK ASSESSMENT;

EID: 77953288303     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.10.004     Document Type: Article

References (65)

1. Watchko J.F. Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels M.J., and Watchko J.F. (Eds). Neonatal jaundice (2000), Harwood, London 169-176
2. Johnson L., Bhutani V.K., Karp K., Sivieri E.M., and Shapiro S.M. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol 29 (2009) S25-S45
3. Maisels M.J., and Newman T.B. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 96 (1995) 730-733
4. Sgro M., Campbell D.M., Fallah S., and Shah V. Kernicterus-January 2007 to December 2009. Canadian Paediatric Surveillance Program 2009. Available at:. http://www.cps.ca/english/surveillance/CPSP/index.htm
5. Manning D., Todd P., Maxwell M., and Platt M.-J. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatol Ed 92 (2007) 342-346
6. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 89 (2000) 1213-1217
7. Banerjee T.K., Hazra A., Biswas A., Ray J., et al. Neurological disorders in children and adolescents. Ind J Pediatr 76 (2009) 139-146
8. Mezaal M.A., Nouri K.A., Abdool S., Safar K.A., and Nadeem A.S.M. Cerebral palsy in adults. Consequences of non progressive pathology. Open Neuro J 3 (2009) 24-26
9. Slusher T.M., Vreman H.J., McLaren D., et al. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin related morbidity and death in Nigerian infants. J Pediatr 126 (1995) 102-108
10. Ebbesen F., Andersson C., Verder H., et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 94 (2005) 59-64
11. American Academy of Pediatrics. Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
12. Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation). Paediatr Child Health 12 (2007) 1B-12
13. Maisels M.J., Bhutani V.K., Bogen D., Newman T.B., Stark A.R., and Watchko J.F. Hyperbilirubinemia in the newborn infant ≥35 weeks' gestation: an update with clarifications. Pediatrics 124 (2009) 1193-1198
14. Bertini G., Dani C., Trochin M., and Rubaltelli F. Is breast feeding really favoring early neonatal jaundice?. Available at:. Pediatrics (2001) 107. http://www.pediatrics.org/cgi/content/full/101/2/e41
15. Newman T.B., Xiong B., Gonzales V.M., and Escobar G.J. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 (2000) 1140-1147
16. Maisels M.J., and Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics 78 (1986) 837-843
17. Maisels M.J., DeRidder J.M., Kring E.A., and Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 29 (2009) 612-617
18. Schneider A.P. Breast milk jaundice in the newborn. A real entity. J Am Med Assoc 255 (1986) 3270-3274
19. Maisels M.J., Gifford K., Antle C.E., and Leib G.R. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics 81 (1988) 505-511
20. De Carvalho M., Klaus M.H., and Merkatz R.B. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child 136 (1982) 737-738
21. Yamauchi Y., and Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics 86 (1990) 171-175
22. Gourley G.R. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 7 (2002) 135-141
23. Auerbach K.G., and Gartner L.M. Breast feeding and human milk: their association with jaundice in the neonate. Clin Perinatol 14 (1987) 89-107
24. Gärtner U., Goeser T., and Wolkoff A.W. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 113 (1997) 1707-1713
25. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology 113 (1997) 1798-1800
26. De Carvalho M., Robertson S., and Klaus M. Fecal bilirubin excretion and serum bilirubin concentration in breast-fed and bottle-fed infants. J Pediatr 107 (1985) 786-790
27. Gourley G.R., Kreamer B., and Arend R. The effect of diet on feces and jaundice during the first three weeks of life. Gastroenterology 103 (1992) 660
28. Verkade H.J. A novel hypothesis on the pathophysiology of neonatal jaundice. J Pediatr 141 (2002) 594-595
29. Nishioka T., Hafkamp A.M., Havinga R., Van Lierop P.P.E., Velvis H., and Verkade H.J. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic gunn rats. J Pediatr 143 (2003) 327-334
30. Gourley G.R. Pathophysiology of breast-milk jaundice. In: Polin R.A., and Fox W.W. (Eds). Fetal and neonatal physiology (1998), Saunders, Philadelphia 1499
31. Yoshioka H. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72 (1983) 317-321
32. Gourley G.R., and Arend R.A. Beta-glucuronidase and hyperbilirubinemia in breast-fed and formula-fed babies. Lancet 1 (1986) 644-646
33. Sirota L., Ferrera M., Lerer N., and Dulitzky F. Beta-glucuronidase and hyperbilirubinaemia in breast fed infants of diabetic mothers. Arch Dis Child 67 (1992) 120-121
34. Monaghan G., McLellan A., McGeehan A., et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 134 (1999) 441-446
35. Maisels M.J. Jaundice. In: MacDonald M.G., Seshia M.M.K., and Mullett M.D. (Eds). Avery's Neonatology (2005), Lippincott Co., Philadelphia, PA 768-846
36. Maisels M.J., and Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation. Pediatrics 117 (2006) 1169-1173
37. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics 103 (1999) 6-14
38. Davidson L.T., Merritt K.K., and Weech A.A. Hyperbilirubinemia in the newborn. Am J Dis Child 61 (1941) 958-980
39. Moyer V.A., Ahn C., and Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 154 (2000) 391-394
40. Kramer L.I. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 118 (1969) 454-458
41. Madlon-Kay D.J. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics 100 (1997) e3
42. Riskin A., Abend-Weinger M., and Bader D. How accurate are neonatologists in identifying clinical jaundice in newborns?. Clin Pediatr 42 (2003) 153-158
43. Szabo P., Wolf M., Bucher H.U., Fauchère J.C., Haensse D., and Arlettaz R. Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer?. Eur J Pediatr 163 (2004) 722-727
44. Keren R., Luan X., Friedman S., Saddlemire S., Cnaan A., and Bhutani V. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 121 (2008) e170-179
45. Maisels M.J., DeRidder J., and Kring E. Transcutaneous bilirubin (TcB) levels in outpatient practice. E-PAS (2007) 618441.5
46. Engle W., Jackson G.C., Stehel E.K., Sendelbach D., and Manning M.D. Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates. J Perinatol 25 (2005) 486-490
47. Maisels M.J., Artinian F., Engle W., McManus S., and Wainer S. Transcutaneous bilirubin (TcB) levels in a mixed race outpatient population - use of a new approach. E-PAS (2009) 2842.398
48. Maisels M.J. Transcutaneous bilirubinometry. Neoreviews 7 (2006) e217-e225
49. Maisels M.J., and Kring E. Trancutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics 99 (1997) 599-601
50. Dai J., Krahn J., and Parry D.M. Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia. Clin Biol 29 (1996) 581-586
51. Ebbesen F., Rasmussen L.M., and Wimberley P.D. A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 91 (2002) 203-211
52. Stevenson D.K., Fanaroff A.A., Maisels M.J., et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 108 (2001) 31-39
53. Alpay F., Sarici S., Tosuncuk H.D., Serdar M.A., Inanc N., and Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 106 (2000) E16
54. Carbonell X., Botet F., Figueras J., and Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 90 (2001) 166-170
55. Kaplan M., Hammerman C., Feldman R., and Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 105 (2000) 533-537
56. Newman T., Liljestrand P., and Escobar G. Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 159 (2005) 113-119
57. Newman T.B. Universal bilirubin screening, guidelines, and evidence. Pediatrics 124 (2009) 1199-1202
58. Trikalinos T., Chung M., Lau J., and Ip S. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics 124 (2009) 1162-1171
59. US Preventive Services Task Force (USPSTF). Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: U.S. Preventive Services Task Force recommendation statement. Pediatrics 124 (2009) 1172-1177
60. Kuzniewicz M.W., Escobar G.J., and Newman T.B. The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use in a managed care organization. Pediatrics 124 (2009) 1031-1039
61. Eggert L., Wiedmeier S.E., Wilson J., and Christensen R. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 117 (2006) e855-e862
62. Longhurst C., Turner S., and Burgos A.E. Development of a web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines. Jt Comm J Qual Patient Saf 35 (2009) 256-262
63. National Quality Forum. Serious reportable events in healthcare: a consensus report (2002), National Quality Forum, Washington, DC
64. Davidson L., and Thilo E.H. How to make kernicterus a "never event". Neoreviews 4 (2003) 308-314
65. Auerbach A.D., Landefeld C.S., and Shojania K. The tension between needing to improve care and knowing how to do it. N Engl J Med 357 (2007) 608-613. *The most important references are indicated with an asterisks.